Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

BDRX
Biodexa Pharmaceuticals plc
stock NASDAQ ADR

At Close
Jul 3, 2025 10:08:18 AM EDT
0.8600USD-2.273%(-0.0200)77,527
0.00Bid   0.00Ask   0.0000Spread
Pre-market
Jul 3, 2025 9:07:30 AM EDT
0.8901USD+1.148%(+0.0101)1,958
After-hours
Jul 3, 2025 4:50:30 PM EDT
0.8515USD-0.988%(-0.0085)200
OverviewPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrends
open chart   
open chart   
Market Cap
4.34M
Headquarters
Abingdon, Oxfordshire, United Kingdom
Industry
Biotechnology
Last Split
Oct 4, 20241for25reverse
BDRX Stats
Avg. Vol. 10 Day
408,832
Avg. Vol. 30 Day
4,388,499
Employees
27
Market Cap
4,336,719
Shares Out.
5,050,631
On/Off Exchange
60%/40%
6 Month Beta
0.76
1 Year Beta
0.97
2 Year Beta
0.94
3 Year Beta
1.00
52 Week Low
0.78
52 Week High
41.50
SMA50
1.18
SMA200
3.57
1 Week
-0.73%
1 Month
-25.34%
3 Month
-47.96%
6 Month
-80.71%
1 Year
-96.09%
2 Year
-99.27%
Profile
midatech is a world leader in the design, synthesis and manufacture of biocompatible gold nanoparticles (gnps) with a core focus on therapeutics for diabetes and cancer. midatech has a strong pipeline of product candidates in clinical and pre-clinical development for the treatment of diabetes and various cancers. in 2012, midatech established midasol therapeutics lp, a strategic joint venture with monosol rx llc to focus on the development and commercialization, via partnering or licensing, of products primarily for the treatment of diabetes. midasol's lead product, midaformâ„¢ insulin pharmfilm, is a unique product for the oral delivery of insulin in diabetic patients and will enter phase ii clinical studies in 2014. these technologies are also being evaluated in the diabetes area by a major us pharmaceutical company. midatech's unique gnp technology enables the administration and targeted delivery of therapeutic compounds to specific cells and tissues. multiple drug molecules can b

BDRX Stock Summary

Biodexa Pharmaceuticals plc (NASDAQ:BDRX) stock price today is $0.8600, and today's volume is 77,527. BDRX is down -2.273% today. The 30 day average volume is 4,388,499. BDRX market cap is 4.34M with 5,050,631 shares outstanding.



Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC